Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

Paul G. Richardson, Edie Weller, Sagar Lonial, Andrzej J. Jakubowiak, Sundar Jagannath, Noopur S. Raje, David E. Avigan, Wanling Xie, Irene M. Ghobrial, Robert L. Schlossman, Amitabha Mazumder, Nikhil C. Munshi, David H. Vesole, Robin Joyce, Jonathan L. Kaufman, Deborah Doss, Diane L. Warren, Laura E. Lunde, Sarah Kaster, Carol DeLaneyTeru Hideshima, Constantine S. Mitsiades, Robert Knight, Dixie Lee Esseltine, Kenneth C. Anderson

Research output: Contribution to journalArticlepeer-review

735 Scopus citations

Fingerprint

Dive into the research topics of 'Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds